Hypoxic Ischaemic Encephalopathy (HIE)

4

Review clinical trials related to Hypoxic Ischaemic Encephalopathy (HIE). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Healing Tiny Minds: Rural Recovery Through Virtual and Lived Experience Care

The goal of this behavioral-interventional study is to learn if the Abecedarian Approach implemented virtually for children ages 0-5 with a history of Hypoxic Ischaemic Encephalopathy (HIE) and/or premature birth produces the same effects as when administered at in-person facilities.

Participants needed: 225
Trial details
Age: Up to 5Biological sex: AllType: InterventionalSponsor: University of Wisconsin, MadisonUpdated: Mar 27, 2026Locations: 1
Eligibility criteria

Term-born children diagnosed during the neonatal period with hypoxic-ischemic en... [+3]

Not suitable for study participation due to other reasons at the discretion of t... [+3]

Status: Recruiting

Genetics of Neonatal Encephalopathy and Related Disorders

Investigators at Boston Children's Hospital are conducting research in order to better understand the genetic factors which may contribute to neonatal encephalopathy (NE) and related disorders. These findings may help explain the broad spectrum of clinical features and outcomes seen in individuals with a history of NE.

Participants needed: 300
Trial details
Biological sex: AllType: ObservationalSponsor: Boston Children's HospitalUpdated: Mar 11, 2026Locations: 1
Eligibility criteria

Diagnosed with neonatal encephalopathy during the neonatal period as documented... [+2]

Genetic cause of NE already identified [+1]

Status: Not yet recruiting

Measuring Heart Health in Both Term, Preterm and Unwell Newborn Babies With an Advanced Ultrasound Method: Speckle Tracking Echocardiography

This study aims to improve how neonatologists check the heart function of newborn babies, especially those who are sick. While standard heart ultrasound scans are useful, a more advanced and sensitive technique called 2D speckle tracking echocardiography (STE) can detect subtle problems with how the heart muscle squeezes and relaxes. This may allow doctors to spot potential issues earlier. Our research will take place at Birmingham Women's Hospital. The investigators will perform these advanced, non-invasive heart scans on several groups of babies: 1. Healthy term and premature babies, to establish a "normal" range of heart function. 2. Babies who are unwell with specific conditions, including those with brain injury due to lack of oxygen at birth (HIE), chronic lung disease of prematurity (BPD), a hole in the diaphragm (CDH), or high blood pressure in their lungs (aPHN). The heart scan is a standard, painless procedure. Using STE does not require any extra scanning time or cause any additional discomfort to the baby; the special images are taken during the routine scan. For many of the sick babies, these scans are already part of their normal clinical care. The main goals of this observational study are to see if STE is a feasible and reliable tool in newborns, to establish normal values for healthy babies, and to track how heart function changes in sick babies during their illness and recovery. Ultimately, the investigators hope this research will provide doctors with a better tool to assess heart health in newborns. This could lead to earlier, more accurate detection of heart problems and help guide treatment decisions to improve outcomes for these vulnerable infants.

Participants needed: 190
Trial details
Age: 0-8Biological sex: AllType: ObservationalSponsor: Birmingham Women's NHS Foundation TrustUpdated: Jan 26, 2026Locations: 1
Eligibility criteria

Neonates who are inpatient at the Birmingham Women's Hospital [+4]

Presence of major congenital heart disease (other than patent foramen ovale or p... [+3]

Status: Recruiting

Feasibility and Safety of Intranasally Administered Breast Milk in HIE

This is a prospective intervention single center study to evaluate the feasibility and safety of intranasal breast milk in hypoxic-ischaemic encephalopathic neonates receiving therapeutic hypothermia.

Participants needed: 10
Trial details
Phase: Early Phase 1Age: Up to 48Biological sex: AllType: InterventionalSponsor: Semmelweis UniversityUpdated: May 22, 2025Locations: 1
Eligibility criteria

Moderate or severe hypoxic- ischaemic encephalopathy, receiving therapeutic hypo... [+4]

Congenital malformation [+5]